Med-Chemist : "Quintessential Medicinal Chemistry"
Friday, February 8, 2019
FDA Approves Osphena (ospemifene) for Moderate to Severe Vaginal Dryness Due to Menopause
›
Duchesnay Inc., a pharmaceutical company specializing in women’s health, announced that the FDA has approved its supplemental New Drug A...
Friday, February 1, 2019
New One-Dose Flu Drug Shows Promise
›
An experimental single-dose flu drug shows promise as a new way to alleviate the misery of influenza , researchers say. The drug...
Wednesday, January 30, 2019
FDA Approves New Indication for Envarsus XR (tacrolimus extended-release tablets)
›
In continuation of my update on Tacrolimus Veloxis Pharmaceuticals announced today that the U.S. Food & Drug Administration (FDA...
Saturday, January 26, 2019
FDA Approves Motegrity (prucalopride) for Adults with Chronic Idiopathic Constipation (CIC)
›
SHPG) has announced that the U.S. Food and Drug Administration (FDA) has approved Motegrity (prucalopride), a once-daily, oral treat...
FDA Grants Priority Review Designation for Heron Therapeutics' NDA for HTX-011, a Non-Opioid for Postoperative Pain Management
›
Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company, announced that the U.S. Food and D...
Friday, January 25, 2019
Lynparza (olaparib) Approved by US FDA for First-Line Maintenance Therapy in BRCA-Mutated Advanced Ovarian Cancer
›
In continuation of my update on olaparib AstraZeneca and Merck & Co., Inc., (Merck: known as MSD outside the US and Canada) anno...
Nabriva Therapeutics Announces Acceptance of the New Drug Application for Intravenous Contepo to Treat Complicated Urinary Tract Infections by FDA
›
Nabriva Therapeutics plc (NASDAQ: NBRV), a clinical-stage biopharmaceutical company announced that the U.S. Food and Drug Administra...
Experimental drug can protect against Ebola in a single dose
›
Dr. Thomas Geisbert, a world-renowned Ebola researcher at The University of Texas Medical Branch, said that previous therapeutics typica...
Thursday, January 24, 2019
FDA Approves Tolsura (SUBA®-itraconazole capsules) for the Treatment of Certain Fungal Infections
›
In continuation of my update on Itraconazole Mayne Pharma Group Limited (ASX: MYX) announced, that the US Food and Drug Administr...
Wednesday, January 23, 2019
FDA Approves Firdapse (amifampridine) for Lambert-Eaton Myasthenic Syndrome
›
The U.S. Food and Drug Administration, approved Firdapse (amifampridine) tablets for the treatment of Lambert-Eaton myasthenic syndrome (...
Tuesday, January 22, 2019
FDA Approves Dextenza (dexamethasone ophthalmic insert) for the Treatment of Ocular Pain Following Ophthalmic Surgery
›
In continuation of my update on Dexamethasone Ocular Therapeutix™, Inc. a biopharmaceutical company focused on the formulation,...
Saturday, January 19, 2019
FDA Approval to Expand the Age Range for Ravicti (glycerol phenylbutyrate) Oral Liquid to Include Newborns
›
In continuation of my update on glycerol phenyl butyrate Horizon Pharma plc (NASDAQ: HZNP) announced the U.S. Food and ...
Friday, January 18, 2019
FDA Approves ProAir Digihaler (albuterol sulfate) as the First and Only Digital Inhaler with Built-In Sensors
›
In continuation of my update on albuterol Teva Pharmaceutical Industries Ltd., announced that the U.S. Food and Drug Administration (FD...
Wednesday, January 16, 2019
FDA Approves Inbrija (levodopa inhalation powder) for Intermittent Treatment of OFF Episodes in People with Parkinson’s Disease
›
In continuation of my update on Levodopa Acorda Therapeutics, Inc. today announced that the U.S. Food and Drug Administration approv...
Tuesday, January 1, 2019
Naloxone Nasal Spray Works Best to Stop Opioid OD...
›
In continuation of my update on naloxone A one-step nasal spray is the easiest form of naloxone to give someone suffering a...
‹
›
Home
View web version